Apeiron Therapeutics is strategically based in the San Francisco Bay Area and in Shanghai, with significant collaborations in the UK enabling us to tap into technologies and talent from all three continents.

Our team and partners bring together deep expertise in applied artificial intelligence (AI) and drug discovery to enable efficient and scalable discovery and development of novel drugs. We apply AI at every stage of the research process from target identification to drug discovery and biomarker elucidation.

To learn more about our team, R&D, or presentations please click on the respective links in the menu bar.